Role on мicroRNA for Diabetes Mellitus Development
Journal Title: Міжнародний ендокринологічний журнал - Year 2016, Vol 1, Issue 73
Abstract
The review presents a brief description of microRNA (miRNA), the mechanism of its formation and functioning. There are also analyzed literature data on miRNA role for diabetes mellitus development. There is generalized the information about participation of various miRNA in insulin production and secretion, tissue differentiation and proliferation, apoptosis genes activation. There is presented the evidence of superior role of miRNA in molecular processes.
Authors and Affiliations
V. P. Pischak, O. M. Riznychuk
Keywords
Related Articles
- EP ID EP207069
- DOI -
- Views 44
- Downloads 0
Analysis of Subclinical Hyperthyroidism Influence on Parameters of Bone Metabolism
State of subclinical hypothyroidism can be considered as the optimal model for assessing the significance of thyroid stimulating hormone (TSH) for bone tissue in clinical practice. Objective: to make a comparative analys...
Hormones of Adipose Tissue and Gestational Diabetes
Obesity and gestational diabetes are the risk factors for complications both in the mother and in the fetus. Adipose tissue hormones (leptin, adiponectin, resistin) are secreted by the human placenta and regulate the fun...
Bone mineral density and trabecular bone tissue quality in obese men
Obesity and osteoporosis are the two metabolic diseases with increased prevalence over last decades and a strong impact on the global morbidity and mortality have gained a status of major health threats worldwide. There...
Analysis of Height Indexes of Girls with Turner Syndrome Depending on Karyotype in Ukrainian Population
Objective: to determine the parameters of stature and bone age in girls with Turner syndrome (TS) in Ukrainian population depending on the age and karyotype, the final height compared with healthy girls, as well as the s...
Blood Fibrinolytic Activity in Patients with Type 2 Diabetes Mellitus Associated with Hypothyroidism
The objective of the research was to study the level of plasminogen activator inhibitor type 1 (PAI-1) in the blood serum of patients with type 2 diabetes mellitus (DM) in combination with hypothyroidism. We have observe...